Work

Weight-Based Dosing of Pembrolizumab Every 6 Weeks in the Time of COVID-19

Year: 2024

Type: article

Abstract: This Viewpoint suggests a new dosage for pembrolizumab treatment that could decrease patients’ exposure risk to COVID-19.

Source: Carolina Digital Repository (University of North Carolina at Chapel Hill)

DOI: 10.17615/eybe-wc94

Authors: Goldstein, Daniel A., Ratain, Mark J., Saltz, Leonard B.

Institution: University of North Carolina at Chapel Hill

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4402028707

FWCI:

Cites:

Cited by:

Related to: 10